This week, Beyond Biotech examined why Western pharmaceutical companies have largely overlooked China's advances in circular RNA therapeutics, a potentially significant blind spot in the global biotech landscape. The episode explores the intersection of scientific innovation, market dynamics, and geopolitical factors that have allowed Chinese researchers to move ahead in this space while their Western counterparts remain cautious. Understanding this gap matters for anyone tracking where the next generation of RNA-based treatments might emerge.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (Jul 27 - Aug 2, 2026)
1 episode · Jul 27 – Aug 2
This Week in Beyond Biotech (Jul 20 - Jul 26, 2026)
1 episode · Jul 20 – Jul 26
This Week in Beyond Biotech (Jul 13 - Jul 19, 2026)
1 episode · Jul 13 – Jul 19
This Week in Beyond Biotech (Jul 6 - Jul 12, 2026)
1 episode · Jul 6 – Jul 12
This Week in Beyond Biotech (Jun 29 - Jul 5, 2026)
1 episode · Jun 29 – Jul 5
This Week in Beyond Biotech (Jun 22 - Jun 28, 2026)
1 episode · Jun 22 – Jun 28
This Week in Beyond Biotech (Jun 15 - Jun 21, 2026)
1 episode · Jun 15 – Jun 21
This Week in Beyond Biotech (Jun 8 - Jun 14, 2026)
1 episode · Jun 8 – Jun 14
This Week in Beyond Biotech (Jun 1 - Jun 7, 2026)
1 episode · Jun 1 – Jun 7
This Week in Beyond Biotech (May 18 - May 24, 2026)
1 episode · May 18 – May 24
This Week in Beyond Biotech (May 11 - May 17, 2026)
1 episode · May 11 – May 17